Evidence map›Paper›PMID 40486200›Full record

ArticleFrontiers in medicine2025

Clinical characteristics and risk factors analysis of allergic bronchopulmonary aspergillosis combined with bronchiectasis.

Qian He, Min Li, Jiaqi Cao, Ming Zhang, Chunlai Feng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qian He *Department of Respiratory and Critical Care Medicine, Third Affiliated Hospital of Soochow University, Changzhou, China.
Min Li *Department of Respiratory and Critical Care Medicine, Xishan People's Hospital of Wuxi City, Wuxi, China.
Jiaqi CaoDepartment of Respiratory and Critical Care Medicine, Third Affiliated Hospital of Soochow University, Changzhou, China.
Ming ZhangDepartment of Respiratory and Critical Care Medicine, Third Affiliated Hospital of Soochow University, Changzhou, China.
Chunlai FengDepartment of Respiratory and Critical Care Medicine, Third Affiliated Hospital of Soochow University, Changzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Allergic bronchopulmonary aspergillosis (ABPA) is a complex pulmonary disorder caused by a hypersensitivity reaction to Methods: We retrospectively collected clinical data from bronchiectasis patients hospitalized at the Third Affiliated Hospital of Soochow University between September 2017 and December 2021. Results: A total of 251 patients were included in the analysis, of which 46 were confirmed to have ABPA with bronchiectasis. The remaining 205 patients served as control group. There were no significant differences in clinical symptoms (fever, cough, hemoptysis, chest pain, wheezing) between the two groups. However, blood eosinophil count and total IgE levels were significantly higher in the ABPA group compared to the control group. Both univariate and multivariable analyses revealed that a higher bronchiectasis severity index (BIS), frequent pet contact, hypoproteinemia, and Conclusion: The clinical symptoms of ABPA in patients with bronchiectasis are clinically indistinguishable from those of non-ABPA bronchiectasis A higher BIS, frequent pet contact, hypoproteinemia, and

Indexed as

allergic bronchopulmonary aspergillosisbronchiectasisclinical characteristicsexacerbationrisk factor

Identifiers

PMID40486200
PMCPMC12140996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.